
    
      Busulfan is a highly toxic drug with narrow therapeutic window used for the conditioning of
      hematopoietic stem cell transplantation. High exposure is associated with systemic toxicity
      such as veno-occlusive disease (VOD) and underexposure is associated with graft failure or
      relapse. In this study we plan to develop a method to determine optimal busulfan dose through
      pharmacokinetic study.
    
  